ClinicalTrials.gg
Drug

Tamoxifen clinical trials

Also written Nolvadex and Soltamox.

studies test it
207
open now
26
in phase 3
73
first study started
1990

How each study uses Tamoxifen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Tamoxifen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Dec 1977 · NOLVADEX · NDA 017970 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tamoxifen
112
tamoxifen citrate
60
TMX
8
TAM
6
Tamoxifen (Nolvadex)
3

Brand

Nolvadex
40
Soltamox
12
KESSAR®
1

Development codes

ICI 46,474
1
ICI-46474
1

Studies by the year they started

203 studies that test it; most in 2017 (13)

Studies that test Tamoxifen, by start year
YearStudies
19902
19911
19922
19937
19942
19954
19966
19974
19986
19992
20006
20017
20028
20037
20047
20052
20064
20076
20087
20095
20105
20118
20123
20131
20146
201510
20165
201713
20187
20196
20204
20217
20228
20234
20245
20259
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
19
Phase 2
97
Phase 3
73
Phase 4
13
No phase
12

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 21 · Other 186

National Cancer Institute (NCI) (8) · AstraZeneca (8) · ETOP IBCSG Partners Foundation (5) · Institut Claudius Regaud (4) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (3) · European Institute of Oncology (3) · Austrian Breast & Colorectal Cancer Study Group (3) · University of California, San Francisco (3)

Often tested with

Tested in the same studies.

Letrozole (26) · Anastrozole (25) · Exemestane (21) · Goserelin (7) · Fulvestrant (5) · Doxorubicin (5) · Palbociclib (4) · Docetaxel (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 10 phase 3 studies under way

Tamoxifen is the comparator. A study of two new drugs counts under both.

  • 2AZD9833 · AstraZeneca · next primary completion Apr 2027
  • 1Giredestrant · Genentech, Inc.
  • 1Imlunestrant · Eli Lilly and Company · next primary completion Oct 2027
  • 1Letrozole · National Cancer Institute, Naples
  • 1Zoledronic Acid · National Cancer Institute, Naples
  • 1Elacestrant · European Organisation for Research and Treatment of Cancer - EORTC · next primary completion Nov 2032
  • 1HRS-8080 · Shandong Suncadia Medicine Co., Ltd. · next primary completion Dec 2030
  • 1Abemaciclib · Japanese Foundation for Cancer Research · next primary completion Feb 2034
Reaching primary completion within a year · 11, 1 in phase 3

Studies that test Tamoxifen, phase 3 first.

Studies

Open first, then newest update. How each study uses Tamoxifen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 207

See all 207 studies that test Tamoxifen →

Given beside what is tested · 75 — Tamoxifen is usual care or a partner of the new treatment

Showing 20 of 75.

As the comparator · 46 — what is tested is compared with Tamoxifen

Showing 20 of 46.

Codes

What other systems call Tamoxifen · ClinicalTrials.gg INT008271

  • MeSH (NLM) D013629TamoxifenConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 094ZI81Y45TAMOXIFENConfirmed FDA, NLM, Wikidata
  • RxNorm 10324Confirmed FDA, Wikidata
  • Wikidata Q412178tamoxifenConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62078TamoxifenOne source FDA
  • DrugBank DB00675One source Wikidata

Also registered as tamoxifen citrate (UNII 7FRV7310N6 · RxNorm 40137).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.